Entia Biosciences Valuation
| ERGO Stock | USD 0.0001 0.00 0.00% |
Entia Biosciences seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Entia Biosciences from reviewing the firm fundamentals such as Current Valuation of 235.63 K, price to sales of 0.89 X, and Price To Earning of (0.50) X as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
Please note that Entia Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Entia Biosciences is based on 3 months time horizon. Increasing Entia Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Entia Biosciences is useful when determining the fair value of the Entia pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Entia Biosciences. Since Entia Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Entia Pink Sheet. However, Entia Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The real value of Entia Pink Sheet, also known as its intrinsic value, is the underlying worth of Entia Biosciences Company, which is reflected in its stock price. It is based on Entia Biosciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Entia Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Entia Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Entia Biosciences helps investors to forecast how Entia pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Entia Biosciences more accurately as focusing exclusively on Entia Biosciences' fundamentals will not take into account other important factors: Entia Biosciences Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Entia Biosciences's current stock value. Our valuation model uses many indicators to compare Entia Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Entia Biosciences competition to find correlations between indicators driving Entia Biosciences's intrinsic value. More Info.Entia Biosciences is one of the top stocks in price to earning category among related companies. It is one of the top stocks in price to sales category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Entia Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Entia Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Entia Biosciences' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Entia Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Entia Biosciences and how it compares across the competition.
About Entia Biosciences Valuation
The pink sheet valuation mechanism determines the current worth of Entia Biosciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Entia Biosciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Entia Biosciences based exclusively on its fundamental and basic technical indicators. By analyzing Entia Biosciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Entia Biosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Entia Biosciences. We calculate exposure to Entia Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Entia Biosciences's related companies.Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon. Total Nutraceutical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.
8 Steps to conduct Entia Biosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Entia Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Entia Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Entia Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Entia Biosciences' revenue streams: Identify Entia Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Entia Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Entia Biosciences' growth potential: Evaluate Entia Biosciences' management, business model, and growth potential.
- Determine Entia Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Entia Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Entia Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Entia Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 24.3 M | |
| Retained Earnings | -14.5 M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entia Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Entia Biosciences information on this page should be used as a complementary analysis to other Entia Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Entia Pink Sheet analysis
When running Entia Biosciences' price analysis, check to measure Entia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entia Biosciences is operating at the current time. Most of Entia Biosciences' value examination focuses on studying past and present price action to predict the probability of Entia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entia Biosciences' price. Additionally, you may evaluate how the addition of Entia Biosciences to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |